Send feedback

DNAJC6 p.Val353Met

c.1057G>A · VCV4741390

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.6964 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00415%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
juvenile onset Parkinson disease 19A

Computational evidence

Protein change
AlphaMissense0.6964likely pathogenic
REVEL0.764pathogenic-leaning
SaProtLLR -12.52damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 10GERP 6, phastCons 1
Regional constrainto/e 0.85unconstrained · MANE · 103 kb · p 3.7e-07 · regional, not allelic
Overall
CADD25.5PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM V296M vs ClinVar V353M) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00415% European (non-Finnish) · 49/1,180,010 alleles
Filtering AF 0.00318% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00286%
Overall 0.00483% 78/1,614,156 alleles · very rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0375% 2,668
European (non-Finnish)grpmax 0.00415% 24,082
Remaining individualsnot grpmax-eligible 0.0032% 31,254
South Asian 0.0022% 45,541
African / African-American 0.00133% 75,050

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DNAJC6
Protein
p.Val353Met
Coding
c.1057G>A
MANE Select
NM_001256864
Type
single nucleotide variant
Location
chr1:65386873 (GRCh38)
Gene constraint
LOEUF 0.416 · pLI 1.00 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 64.29
Residue 353
the c2 tensin-type domain
Full DNAJC6 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

juvenile onset Parkinson disease 19A — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Atypical juvenile parkinsonism (Orphanet):

Inheritance
Autosomal recessive, Not applicable
Onset
Adolescent, Adult

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dnajc6-p-val353met (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown